Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
14,099
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Astellas Pharma Inc. - ADR market cap is $30.84B.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Astellas Pharma Inc. - ADR 52 week high is $17.46 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Astellas Pharma Inc. - ADR 52 week low is $12.25 as of November 22, 2026.
Astellas Pharma Inc. - ADR stock price today is $17.20.
Astellas Pharma Inc. - ADR stock price yesterday was $17.15.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Astellas Pharma Inc. - ADR's P/E ratio is 12.6.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Astellas Pharma Inc. - ADR P/B ratio is 2.4455.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Astellas Pharma Inc. - ADR 50-day moving average is $15.49.